Navigation Links
China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
Date:10/9/2008

HARBIN, China, Oct. 9 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the health and nutritional food industry engaged in the development, manufacture and distribution of nutritional food products, dietary supplements, and raw cactus plants in the People's Republic of China ("PRC"), today announced that the Board of Directors of the Company has approved and authorized a share repurchase program for up to $2 million of its common stock.

China Yingxia will repurchase shares on the open market or through privately negotiated transactions through September 30, 2009, in compliance with the rules and regulations of the U.S. Securities and Exchange Commission. The final number of shares repurchased and the timing of the purchases will depend on market conditions, share price, applicable legal requirements, and other factors deemed appropriate by the Board of Directors. The repurchase program may be discontinued or expanded by the Board of Directors in the future.

The repurchases will be funded with available cash on hand. As of August 14, 2008, the Company had 44.5 million common shares outstanding and approximately 10.9 million freely traded shares. Any shares repurchased by the Company in this program will reduce the number common shares outstanding.

"Our strong balance sheet provides us with the opportunity to return value to our shareholders through a stock repurchase program without impacting our ability to engage in new investments for future growth. We have recently completed the most capital intensive phase of our growth plan by increasing production capacity. Now we will focus on expanding our franchisee-based distribution network and product offerings," said Ms. Yinxia Jiao, CEO and Chairwoman of China Yingxia. "We expect our cash position to further improve in the near future due to profitable operations, reduction in inventory and
'/>"/>

SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...l temperatures and energy costs continue to soar, ...inable future. An attractive replacement for gas...ine in Genome Research ( www.genome.org ), scien...hanol-producing microorganisms, uncovering genetic...hnologies needed to implement production on a glob...
(Date:11/6/2009)...6 Helix BioPharma Corp. ...nced that John Docherty, president and chief opera...,s 6th annual Investor Summit on November 10, 2009... Mr. Docherty will provide an overview of the Com...7 and Topical Interferon Alpha-2b. The slide show...
(Date:11/6/2009)...swire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ON...day announced updated results from a Phase II stud...omas metastatic to the lung in a poster presentati...ociety Meeting held in Miami Beach, Florida, from ...tled "A Phase II Study of Intravenous REOLYSIN (Wi...
(Date:11/5/2009).... 5 The endangered black-footed fe.... This rare carnivore feeds on prairie dogs. Th...often entire population die-offs in towns occur. ...lemented a ferret breeding program and has been re...ly native habitat. Unfortunately, plague can swee...
Breaking Biology Technology:Genomes of biofuel yeasts reveal clues that could boost fuel ethanol production worldwide 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2
...MISSISSAUGA, ON, Dec. 20 /PRNewswire-FirstCall/ - ...BA), an oncology company that identifies,develops ...ients worldwide,today announced that it has comple...Phase II trial of nimotuzumab in combination with ... The safety profile in the trial to,date is consis...
...Avon Walk Adds Houston, TX to 2008 Lineup; Looks t...eaking Results, NEW YORK, Dec. 20 Underscoring i...e and finding a cure for breast cancer, the Avon,F...reast Cancer schedule.,For the first time in Avon ...market -- Houston -- to build upon the momentum of...
...CARLSBAD, Calif., Dec. 20 Ardea Biosciences,Inc. ...ry and development of,small-molecule therapeutics ...flammatory diseases, today announced that it has e...ertain institutional investors to raise,approximat...oximately 3.0,million newly issued shares of its c...
Other Biology Technology:YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB COLORECTAL CANCER TRIAL FIRST COHORT IS CLOSED TO ACCRUAL 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB COLORECTAL CANCER TRIAL FIRST COHORT IS CLOSED TO ACCRUAL 3Avon Foundation Announces 2008 Avon Walk for Breast Cancer Schedule 2Avon Foundation Announces 2008 Avon Walk for Breast Cancer Schedule 3Ardea Biosciences Announces $40 Million Private Placement 2Ardea Biosciences Announces $40 Million Private Placement 3
(Date:11/9/2009)...RMINGHAM, Ala. The U.S. Department of Energy (DOE...ersity of Alabama at Birmingham (UAB) School of En...reenhouse gas emissions through the capture and pe...dioxide (CO2). The project is in collaboration wit...Power. , Funded by the DOE through the 2009 Amer...
(Date:11/9/2009)...am of academic, government and industry researcher...hot esculenta) genome. The project is an important...n this subsistence crop and addressing some of the... the world. , Cassava is a root crop that serves...ion people each day. Although it has many properti...
(Date:11/9/2009)..., the Netherlands, November 09, 2009 / b3c newswi...anization, and Seventh Wave, an American organizat...e that the companies have signed a letter of inten...estinal models TIM. The letter of intent proposes ...two TIM systems for commercialization in North Ame...
Breaking Biology News(10 mins):UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3Researchers complete draft genome sequence for cassava 2Researchers complete draft genome sequence for cassava 3Researchers complete draft genome sequence for cassava 4TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2LeadConfirm Professional the First Oral Based Lead Test Makes Getting the Lead Out Easier Now Available at Amazon com 51078 1LeadConfirm Professional the First Oral Based Lead Test Makes Getting the Lead Out Easier Now Available at Amazon com 51078 2LeadConfirm Professional the First Oral Based Lead Test Makes Getting the Lead Out Easier Now Available at Amazon com 51078 3LeadConfirm Professional the First Oral Based Lead Test Makes Getting the Lead Out Easier Now Available at Amazon com 51078 4Team Golds Gym Continues to Lead the National Fight Against Diabetes 51073 1Team Golds Gym Continues to Lead the National Fight Against Diabetes 51073 2Team Golds Gym Continues to Lead the National Fight Against Diabetes 51073 3VirtualScopics Reports Record Revenue 51069 1VirtualScopics Reports Record Revenue 51069 2
..., MADISON Individuals with a rare genetic conditi...ficult-to-follow prescription. They must severely ...iding mealtime staples such as meat, cheese and ev...nstant struggle. , In an effort to expand their di...adison scientists is assessing a unique protein fo...
...ASHINGTON, Feb. 1 The U.S. Department of Homeland...collecting additional,fingerprints from internatio...continental Airport (Bush Intercontinental). The c...- to 10-fingerprint collection to enhance,security...ly and,efficiently establishing and verifying visi...
... The Stowers Institutes Trainor Lab has demonstra...development of the nervous system, a process that ...re neural cells with the cycle of cell division th...sms regulating these distinct cellular activities ...l be published in the Feb. 15 issue of Development...
Other Biology News:Unique whey protein is promising supplement for strict PKU diet 2Unique whey protein is promising supplement for strict PKU diet 3DHS Begins Collecting 10 Fingerprints From International Visitors at George Bush Houston Intercontinental Airport 2Trainor Lab characterizes gene essential for prenatal development of nervous system 2
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Mouse Anti-IFN-g / CD69 / CD4 / CD3 BDFastImmune Antibody, APC, PerCP-Cy5.5, PE, FITC Conjugated from BD Biosciences - Immunocytometry Systems
Mouse Anti-Transferrin, N-terminus Monoclonal Antibody, Unconjugated, Clone 236-18241 from Meridian Life Science, Inc.
Rabbit Anti-Phosphothreonine-X-Phosphotyrosine Polyclonal Antibody, Horseradish Peroxidase Conjugated from Abcam
Biology Products: